tbuckley/cabot-search huggingface dataset:
Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,
Authors: Mark N Polizzotto, Amanda J Zatta, Merrole F Cole-Sinclair, Erica M Wood, Zoe K McQuilten, Scott Dunkley, Peter Cameron, Louise E Phillips
Journal: Blood (2011)
Serious Late Complications After Hematopoietic Stem Cell Transplantation (HSCT) Following Myeloablative Conditioining (MAC) In Infants.
Authors: Masahiro Yasui, Kayo Yamada, Osamu Kondo, Maho Sato, Akihisa Sawada, Sadao Tokimasa, Keisei Kawa, Masami Inoue
Journal: Blood (2010)
Excess Heparan Sulphate Inhibits CXCL12-Mediated Hematopoietic Cell Migration and Engraftment After Bone Marrow Transplant in Mice with Mucopolysaccharidosis Type I,
Authors: H. Angharad Watson, Rebecca J Holley, Kia J Langford-Smith, Fiona L Wilkinson, Toin H van Kuppevelt, Robert Wynn, J. Ed Wraith, Catherine L R Merry, Brian W Bigger
Journal: Blood (2011)
Eculizumab (ECU) Safety and Efficacy in Atypical Hemolytic Uremic Syndrome (aHUS) Patients with Long Disease Duration and Chronic Kidney Disease (CKD): 2-Year Results
Authors: Christoph Licht, Petra Muus, Christophe M. Legendre, Kenneth W. Douglas, Maryvonne Hourmant, Yahsou Delmas, Maria Herthelius, Antonella Trivelli, Timothy H. J. Goodship, Camille L. Bedrosian, Chantal Loirat
Journal: Blood (2012)
Expression Pattern of WT1 Isoforms in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Severe Aplastic Anemia (SAA)
Authors: Karolina Kramarzova, Andre Willasch, Bernd Gruhn, Jiri Schwarz, Jana Markova, Jan Stary, Jan Trka, Ludmila Boublikova
Journal: Blood (2011)
Unexpected Harm From an Intensive COPD Intervention
Authors: Seppo T. Rinne, Peter K. Lindenauer, David H. Au
Journal: JAMA (2019)

Hanan Aboumatar, MD, MPH; Mohammad Naqibuddin, MBBS, MPH; Suna Chung, MPH; Hina Chaudhry, MPH; Samuel W. Kim, BA; Jamia Saunders, MD, MS; Lee Bone, MPH; Ayse P. Gurses, MS, MPH, PhD; Amy Knowlton, ScD, MPH; Peter Pronovost, MD, PhD; Nirupama Putcha, MD, MHS; Cynthia Rand, PhD; Debra Roter, DrPH; Carol Sylvester, RN, MS; Carol Thompson, MS, MBA; Jennifer L. Wolff, PhD; Judith Hibbard, PhD, MPH, FCCM; Robert A. Wise, MD
Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: An Interim Analysis Of The Kids B-LONG Study
Authors: Kathelijn Fischer, Roshni Kulkarni, Myles Bradbury, Margaret V. Ragni, Savita Rangarajan, Yingwen Dong, Shuanglian Li, Haiyan Jiang, Karen Nugent, Glenn F Pierce, Geoffrey Allen
Journal: Blood (2013)
The Addition of Bortezomib to Modified R-CHOP as Initial Therapy for Follicular NHL Results in High CR Rate and Is Well Tolerated.
Authors: Rajni Sinha, Jonathan L. Kaufman, Hanna Jean Khoury, Nassoma King, Pareen J. Shenoy, Carol Lewis, Kevin Bumpers, Sagar Lonial, Christopher R. Flowers
Journal: Blood (2009)
Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial
Authors: Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, Edmund K Waller, Daniel J. Weisdorf, John R. Wingard, Corey S. Cutler, Peter Westervelt, Ann Woolfrey, Stephen Couban, Laura Johnston, Richard T. Maziarz, Michael Pulsipher, Paolo Anderlini, William I Bensinger, Susan F. Leitman, Scott D Rowley, Shelly L Carter, Mary M. Horowitz, Dennis L Confer
Journal: Blood (2011)
Modulation of the fungal mycobiome is regulated by the chitin-binding receptor FIBCD1
Authors: Jesper B. Moeller, Irina Leonardi, Anders Schlosser, Anne-Laure Flamar, Nicholas J. Bessman, Gregory Garbès Putzel, Theresa Thomsen, Mark Hammond, Christine S. Jepsen, Karsten Skjødt, Ernst-Martin Füchtbauer, Donna L. Farber, Grith L. Sorensen, Iliyan D. Iliev, Uffe Holmskov, David Artis
Journal: The Journal of Experimental Medicine (2019)

Host–microbiota interactions are critical in regulating mammalian health and disease. In addition to bacteria, parasites, and viruses, beneficial communities of fungi (the mycobiome) are important modulators of immune- and tissue-homeostasis. Chitin is a major component of the fungal cell wall, and fibrinogen C containing domain 1 (FIBCD1) is a chitin-binding protein; however, the role of this molecule in influencing host–mycobiome interactions in vivo has never been examined. Here, we identify direct binding of FIBCD1 to intestinal-derived fungi and demonstrate that epithelial-specific expression of FIBCD1 results in significantly reduced fungal colonization and amelioration of fungal-driven intestinal inflammation. Collectively, these results identify FIBCD1 as a previously unrecognized microbial pattern recognition receptor through which intestinal epithelial cells can recognize and control fungal colonization, limit fungal dysbiosis, and dampen intestinal inflammation.
DISTINCT ROLES for Rap1b In PLATELET SECRETION and INTEGRIN aIIBb3 OUTSIDE-In SIGNALING
Authors: Guoying Zhang, Binggang Xiang, Ye Shaojing, Magdalena Chrzanowska-Wodnicka, Andrew J. Morris, T. Kent Gartner, Sidney W. Whiteheart, Gilbert C. White, Susan S. Smyth, Zhenyu Li
Journal: Blood (2011)
Is a Universal Influenza Virus Vaccine Possible?
Authors: Raffael Nachbagauer, Peter Palese
Journal: Annual Review of Medicine (2019)

Influenza viruses remain a severe burden to human health because of their contribution to overall morbidity and mortality. Current seasonal influenza virus vaccines do not provide sufficient protection to alleviate the annual impact of influenza and cannot confer protection against potentially pandemic influenza viruses. The lack of protection is due to rapid changes of the viral epitopes targeted by the vaccine and the often suboptimal immunogenicity of current immunization strategies. Major efforts to improve vaccination approaches are under way. The development of a universal influenza virus vaccine may be possible by combining the lessons learned from redirecting the immune response toward conserved viral epitopes, as well as the use of adjuvants and novel vaccination platforms.
Use of Rituximab with CHOP Chemotherapy Appears to Overcome Racial Disparities In Survival In Black Patients with Diffuse Large B Cell Lymphoma When Compared to CHOP Chemotherapy Alone.
Authors: Uma Borate, Pareen J Shenoy, Will Donnellan, Kevin Bumpers, Tanyanika Douglas-Holland, Nassoma King, Mary Jo Lechowicz, Angelina The, David L Jaye, Vishnu Reddy, Christopher R Flowers, James M. Foran
Journal: Blood (2010)
Abstract 11878: Bendavia, a Novel Mitochondria Targeting Peptide, Improves Mitochondrial Function in Circulating Blood Monocytes From Dogs With Chronic Heart Failure
Authors: Hani Sabbah, Vinita Sing-Gupta, Ramesh C Gupta
Journal: Circulation (2015)

Introduction: We previously showed that mitochondrial (MITO) function of the failing heart is abnormal as evidenced by reduced MITO respiration and reduced MITO ATP synthesis. We also showed that this abnormality extends to MITO of circulating blood monocytes (MCs). Therapy with Bendavia, a novel MITO targeting peptide, has been shown to normalize MITO function of failing cardiomyocytes. Hypothesis: Bendavia will also normalize abnormalities of MITO function of MCs of dogs with chronic heart failure (HF). Methods: Peripheral blood samples were obtained from 6 normal (NL) dogs and 6 dogs with coronary microembolizations-induced HF (LV ejection fraction ~30%) and used to isolate MCs by sequential Ficoll and Percoll density gradients. An XFe/XF96 analyzer (Seahorse Bioscience) was used to measure oxygen consumption rates (OCR) in MCs in the presence and absence of 1 μM oligomycin, 0.5 μM FCCP, or 1 μM each rotenone and antimycin. MITO proton leak, maximal respiration (MAXresp), and spare respiratory capacity (SRC) were measure in the presence and absence of 0.1, 1.0 and 10 μM concentrations of Bendavia and results expressed in pmols OCR/min/μg protein. Results: Proton leak, MAXresp and SRC were abnormal in MCs of HF dogs compared to NL dogs. Incubation with Bendavia had no effect on any of the measures of MCs MITO function of NL dogs (Table). In contrast, MITO function of MCs from HF dogs was nearly normalized after treatment with Bendavia (Table). Conclusions: MITO function is abnormal in circulating blood MCs of dogs with HF. Bendavia had no effect on MITO function of MCs from NL dogs. Treatment with Bendavia of MCs from HF dogs elicited a dose-dependent correction/normalization of MITO function. These findings support the use of circulating blood MCs as means of assessing MITO dysfunction in HF and as a marker of potential benefits derived from treatment with MITO targeted therapies.
Pain Management With Opioids in 2019-2020
Authors: Evan Wood, David L. Simel, Jan Klimas
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Targeting TKI-Insensitive CML Stem/Progenitor Cells By Effective Inhibition of a Novel PP2A-AHI-1-BCR-ABL-JAK2 Complex
Authors: Damian Lai, Xiaohu Liu, Min Chen, Katharina Rothe, Kaiji Hu, Sandra Dunn, Xiaoyan Jiang
Journal: Blood (2014)
Correction of Artemis Deficiency In Murine Hematopoietic Stem Cell by I-Sce 1 Meganuclease and Artemis Recombination Matrix Mediated Homologous Recombination.
Authors: Julie Rivière, Julia Hauer, Laurent Poirot, Julien Brochet, Frédéric Pâques, Jean-Pierre De-Villartay, Alain Fischer, Marina Cavazzana-Calvo
Journal: Blood (2010)
Reduced Costs and Length-of-Stay Associated with Rivaroxaban As Compared to Parenteral Bridging and Warfarin in Pulmonary Embolism Patients Managed in Observation Status
Authors: Christine G Kohn, Erin R Weeda, W Frank Peacock, Gregory J Fermann, Christopher W. Baugh, Philip S Wells, Veronica Ashton, Concetta Crivera, Peter Wildgoose, Jeff Schein, Craig I Coleman
Journal: Blood (2016)
Efficacy of Third Party BK Virus (BKV) Specific Cytotoxic T-Lymphocytes Generated By Ex Vivo Expansion for the Treatment of BKV Infection in Stem Cell Transplant Recipients, a Phase 2 Trial
Authors: Amanda L. Olson, Muharrem Muftuoglu, Indreshpal Kaur, Li Li, Glorette Abueg, Roy Chemaly, Eric Yvon, Peter F Thall, David Marin, Amin M. Alousi, Sairah Ahmed, Stefan O. Ciurea, Chitra Hosing, Partow Kebriaei, Roy Jones, Borje S Andersson, Nina Shah, Betul Oran, Ala Abudayyeh, Uday R. Popat, Richard E. Champlin, Elizabeth J Shpall, Katy Rezvani
Journal: Blood (2016)
The Effect of Bortezomib On Bone Metabolism of Patients with Multiple Myeloma: a Korean Multicenter Prospective Study.
Authors: Chang-Ki Min, Seok Jin Kim, Je-Jung Lee, Cheolwon Suh, Jin Seok Kim, Sung-Soo Yoon, Byung Soo Kim, Hye Jin Kang, Young Jin Choi, Cheol Soo Kim, Yang Soo Kim, Jae-Yong Kwak, Yoo Jin Kim, Young Don Joo, Yeung-Chul Mun, Deog Yeon Jo, Joon Seong Park, Chi-Young Park, Sung Hyun Kim
Journal: Blood (2009)
N-Linked Glycans within the A1A2A3 Domains of VWF Play a Critical Role in Modulating Macrophage-Mediated Clearance
Authors: Alain Chion, Jamie O'Sullivan, Gudmundur Bergsson, Sean Keyes, Orla Rawley, Padraic Fallon, Nico van Rooijen, Michael Laffan, Thomas Anthony Jude McKinnon, Teresa Brophy, James S O'Donnell
Journal: Blood (2014)
Scl and Notch Act Downstream of Hedgehog Signaling to Promote Embryonic Hematopoiesis From Endothelial Cells
Authors: Peter G Kim, Colleen E Albacker, Il-ho Jang, Garrett C Heffner, Yoowon Lim, Teresa V. Bowman, Michelle I Lin, Leonard I. Zon, Sabine Loewer, George Q. Daley
Journal: Blood (2011)
Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial
Authors: David S. Siegel, Meletios Athanasios Dimopoulos, Sung-Soo Yoon, Jacob P. Laubach, Jonathan L. Kaufman, Hartmut Goldschmidt, Donna E. Reece, Xavier Leleu, Simon Durrant, Fritz C. Offner, Michele Cavo, Arnon Nagler, Sundar Jagannath, Thorsten Graef, Jennifer Houp, Linda Sun, Jason Howe, Sandra M. Wear, Kenneth C. Anderson
Journal: Blood (2011)
Intrinsic Biological Variability In High-Risk-Myelodysplastic Syndrome Impacts Overall Survival (OS) In Patients Experiencing Cytogenetic Evolution Treated With Azanucleosides
Authors: Ruben Hernandez Perez, Ang Li, Sarvari Venkata Yellapragada, Matthew Zheng, Maria Otazo, Martha Mims, Gustavo A. Rivero
Journal: Blood (2013)
An Open Label, Non Randomized, Propspective Phase IV Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars In Healthy Volunteers.
Authors: Marise Gomes, Eduardo Ramacciotti, Debra Hoppensteadt, Jeanine M. Walenga, Bruce E Lewis, Walter Jeske, Jawed Fareed
Journal: Blood (2010)
Notes from the field: Acute Hepatitis and Liver Failure Following the Use of a Dietary Supplement Intended for Weight Loss or Muscle Building — May–October 2013
Authors: Sarah Y. Park, Melissa Viray, David Johnston, Ethel Taylor, Arthur Chang, Colleen Martin, Joshua G. Schier, Lauren S. Lewis, Kara M Levri, Kevin Chatham-Stephens
Journal: MMWR Morbidity and Mortality Weekly Report (2013)
Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy
Authors: Gheath Alatrash, Pariya Sukhumalchandra, Mao Zhang, Anna Sergeeva, Haroon Jakher, Jinsheng Weng, Lisa S St. John, Kathryn Ruisaard, Karen Clise-Dwyer, Sijie Lu, Jeffrey J. Molldrem
Journal: Blood (2012)
Prognostic Relevance of Dose-Density of DHAP-Reinduction Therapy in Relapsed HL: An Analysis of the German Hodgkin-Study Group (GHSG)
Authors: Stephanie Sasse, Magdalena Alram, Horst Mueller, Lenka Smardova, Bernd Metzner, Hartmut Döhner, Thomas Fischer, Vladan Vucinic, Norbert Schmitz, Kerstin Schäfer-Eckart, John M. Raemaekers, Oliver Schmalz, Bastian von Tresckow, Andreas Engert, Peter Borchmann
Journal: Blood (2012)
Randomized phase II study of CDDP+S-1 vs CDDP+PEM combined with thoracic RT for locally advanced non-squamous NSCLC
Authors: Atsushi Horiike, Makoto Nishio, Seiji Niho, Tatsuya Yoshida, Tetsuo Akimoto, Kentaro Sakamaki, Toshiaki Takahashi, Takashi Seto, Noboru Yamamoto, Toyoaki Hida, Hiroaki Okamoto, Takayasu Kurata, Miyako Satouchi, Koichi Goto, Takeharu Yamanaka, Yuichiro Ohe
Journal: Annals of Oncology (2019)
Dissecting the Mechanisms of Activity of SLAMF7 and the Targeting Antibody Elotuzumab in Multiple Myeloma
Authors: Siobhan Glavey, Michaela Reagan, Salomon Manier, Michele Moschetta, Yawara Kawano, Antonio Sacco, Aldo M Roccaro, Michael Robbins, Irene M. Ghobrial
Journal: Blood (2014)
Expansion and Multipotencial Differentiation of Mesenchymal Stem Cells Isolated from Patients after High Dose Chemotherapy.
Authors: Karen L. Prata, Maristela D. Orellana, Aparecida M. Fontes, Karina R. Solano, Simone Kashima, Rita C.V. Carrara, Patrícia V.B. Palma, Luciana C.O. Oliveira, Belinda P. Simões, Luciano Neder, Antonio D. Campos, Marco A. Zago, Dimas T. Covas
Journal: Blood (2006)
High Resolution Array-Based CGH and SNP Studies of AML Genomes.
Authors: Matthew J. Walter, R. Ries, X. Li, W. Shannon, J. Payton, J. Books, C. Bloomfield, K. Mrozek, A. Ruppert, J. DiPersio, D. Link, M. Tomasson, T. Graubert, P. Westervelt, M. Watson, S. Heath, J. Baty, J. Armstrong, E. Mardis, R. Wilson, R. Selzer, T. Richmond, J. Kitzman, P. Eis, T. Ley
Journal: Blood (2007)
T Cell Repertoire Diversity of Sickle Cell Anemia Patients Treated with Allogeneic Hematopoietic Stem Cell Transplantation and Conventional Treatments
Authors: Luciana Ribeiro Jarduli, Adriana Aparecida Marques, Julia Teixeira Cottas de Azevedo, Keli Cristina de Lima, Wilson Araújo da Silva Júnior, Dimas Tadeu Covas, Belinda Pinto Simoes, Ana Cristina Silva Pinto, Kelen Cristina Ribeiro Malmegrim de Farias
Journal: Blood (2016)
Brain mapping for lesions in primary motor cortex: integrated surgical approach
Authors: José Lavrador, Prajwal Ghimire, Christian Brogna, Luciano Furlanetti, Sabina Patel, Richard Gullan, Keyoumars Ashkan, Ranjeev Bhangoo, Francesco Vergani
Journal: Neuro-Oncology (2019)

Abstract Background Lesions within the corticospinal tract (CST) represent significant surgical challenge with a delicate functional trade-off that should be integrated in the overall patient-centred treatment plan. Methods Patients with lesions within the CST with preoperative cortical and subcortical mapping (nTMS and tractography), intraoperative mapping and intraoperative provisional histological information (smear +- 5-ALA) were included. This independently acquired information was integrated in a decision-making process model to determine the intraoperative extent of resection. Results 10 patients (6 patients with metastatic precentral tumour; 1 patient with Grade III and 2 patients with grade IV gliomas; 1 patient with precentral vascular malformation) were included in the study. Majority of the patient had pre-operative motor deficit (60%). 50% patients underwent gross total resection and 40% patients underwent near total resection of the lesions. In only one patient, no surgical resection was possible after both pre-operative and intraoperative mapping. 70% of patients remained stable postoperatively and 20% improved from previous motor weakness. Conclusion The independently acquired anatomical (anatomical MRI) and functional (nTMS and tractography) in patients with CST lesions provide a more accurate guide for resection. The inclusion of the histological information (smear +- 5-ALA) further allows the surgical team to balance the potential functional risks within the global treatment plan. Therefore, the patient is kept at the centre of the informed decision making process.
Serum Albumin and Peripheral Blood Lymphocyte/Monocyte Ratio at Diagnosis May Provide Additional Prognostic Information in R-IPI Good Risk Diffuse Large-B-Cell Lymphoma Patients Treated with R-CHOP
Authors: Branimir Spassov, Donka Vassileva, Georgi Michaylov, Gueorgui Balatzenko, Margarita Guenova
Journal: Blood (2015)
Infusion of Haploidentical Stem Cell after Consolidation in Younger Patients with Acute Myeloid Leukemia: Preliminary Results of a Phase I-II Study
Authors: Blanca Boluda, Pau Montesinos, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, Jaime Sanz, Amparo Sempere, Leonor Senent, Pilar Solves, Ines Gómez-Seguí, Lourdes Cordon, Mariam Ibáñez, Juan Montoro, Anabel Regadera, Dolores Planelles, Guillermo Sanz, Antonio Torres, Miguel A. Sanz
Journal: Blood (2016)
Monoallelic Methylation of the Human Androgen Receptor Gene as Detected by the HUMARA Clonality Assay Does Not Consistently Reflect X-Chromosome Inactivation and Is Therefore Unreliable for Assessment of Clonal Hematopoiesis.
Authors: Sabina Swierczek, Jaroslav Jelinek, Neeraj Agarwal, Andrew Wilson, Kimberly Hickman, Charles J. Parker, Josef T. Prchal
Journal: Blood (2009)
Incidence and Clinical Characteristics of Chronic Graft Versus Host Disease (cGVHD) According to the National Institutes of Health (NIH) Criteria in Patients Transplanted for Acute Myeloid Leukemia (AML).
Authors: Arturo Vega, Peter Martus, Theis Terwey, Christian Jakob, Lam G Vuong, Philipp Hemmati, Philipp D. le Coutre, Renate Arnold
Journal: Blood (2009)
The Addition of Rituximab to CVP (Bagley) + Interferon-α as Induction Regimen, Significantly Increases Complete Remission Rates and Progression Free Survival In Intermediate-High Risk Follicular Lymphoma Patients (LNH-pro vs. LNH-pro-05 trial)
Authors: Jimena Cannata-Ortiz, Concepción Nicolás, Ana García-Noblejas, Javier Lopez, Maria José Requena, Concepción Alaez, Adrian Alegre, Reyes Arranz
Journal: Blood (2010)
p21WAF1/CDKN1 Function In Hematopoietic Progenitor Cell Proliferation Is Inversely Regulated by Wild-Type Flt3 and Internal Tandem Duplication Mutation of Flt3
Authors: Mariko Abe, Louis M. Pelus, Pratibha Singh, Seiji Yamaguchi, Takeshi Taketani, Seiji Fukuda
Journal: Blood (2010)
CD33 Splicing Polymorphism Is a Strong Predictor of Therapeutic Efficacy of Gemtuzumab Ozogamicin in De Novo AML: Report from COG-AAML0531 Study
Authors: Jatinder K Lamba, Lata Chauhan, Michael R. Loken, Jessica Pollard, Yi-Cheng Wang, Ries E Rhonda, Richard Aplenc, Betsy A. Hirsch, Susana C. Raimondi, Roland B. Walter, Irwin D. Bernstein, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi
Journal: Blood (2016)
CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL
Authors: Paolo Bernasconi, Marina Boni, Irene Dambruoso, Ilaria Giardini, Paola Maria Cavigliano, Barbara Rocca, Rita Zappatore, Celeste Calvello, Marilena Caresana, Lara Pochintesta, Silvia Zibellini, Mario Lazzarino, Ester Orlandi
Journal: Blood (2010)
Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma
Authors: Fengting Yan, Porsha Smith, Lapo Alinari, John Ryu, Bo Yu, Vrajesh Karkhanis, Sookil Tae, John T. Patton, Emily E. Wilding, Kate Gordon, Kiran Mahasenan, Deepak Bhasin, Claudio Agostinelli, Stefano A. Pileri, John C. Byrd, Said Sif, Pui-kai Li, Chenglong Li, Robert A. Baiocchi
Journal: Blood (2011)
GATA1 Mutations in Transient Leukemia and Myeloid Leukemia in “Down” Syndrome.
Authors: Katarina Reinhardt, Katarina Boehmer, Jan-Henning Klusmann, Manuela Germeshausen, Annette Sander, Christine von Neuhoff, Jan Stary, Heribert Jürgens, Arnulf Pekrun, Axel Sauerbrey, Charlotte M Niemeyer, Gudrun Fleischhack, Ursula Creutzig, Dirk Reinhardt
Journal: Blood (2008)
Characterization of the Hematopoietic Stem and Progenitor Cell Hierarchy in Myelodysplastic Syndromes Patients with Monosomy 7 As the Sole Cytogenetic Abnormality
Authors: Marios Dimitriou, Teresa Mortera-Blanco, Petter S Woll, Mohsen Karimi, Helen Doolittle, Sten Eirik W Jacobsen, Eva Hellstrom-Lindberg
Journal: Blood (2014)
Review: Extended therapy with DOACs, but not VKAs, reduces mortality after VTE treated with initial anticoagulation
Authors: Anthony Donato, Daniel Forman
Journal: Annals of Internal Medicine (2019)

Source Citation Mai V, Guay CA, Perreault L, et al. Extended anticoagulation for VTE: a systematic review and meta-analysis. Chest. 2019;155:1199-216. 31174635
A Multi-Center Phase II Study (SAKK 36/06) of Single Agent Everolimus (RAD001) In Patients with Relapsed or Refractory Mantle Cell Lymphoma.
Authors: Christoph Renner, Pier Luigi Zinzani, Remy Gressin, Dirk Klingbiel, Laurence Favet, Felicitas Hitz, Mario Bargetzi, Walter Mingrone, Giovanni Martinelli, Urs Breitenstein, Krimo Bouabdallah, Christine Biaggi, Sergio Cogliatti, Nicolas Ketterer
Journal: Blood (2010)
Effect of Azacytidine on the Hematopoietic Stem and Progenitor Cell Compartments of MDS Mouse Models: Unveiling the Mechanisms of Remission and Relapse
Authors: Irene Gañán-Gómez, Yamini Ogoti, Matteo Marchesini, Yue Wei, Hui Yang, Shan Jiang, Naran Bao, Carlos E. Bueso-Ramos, Guillermo Garcia-Manero, Simona Colla
Journal: Blood (2015)